Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

12.41
-1.5500-11.10%
Post-market: 12.410.00000.00%19:49 EDT
Volume:4.95M
Turnover:61.71M
Market Cap:1.91B
PE:-31.65
High:13.86
Open:13.84
Low:12.02
Close:13.96
52wk High:20.76
52wk Low:6.68
Shares:153.78M
Float Shares:117.37M
Volume Ratio:2.82
T/O Rate:4.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3922
EPS(LYR):-0.3922
ROE:-27.82%
ROA:-6.79%
PB:8.72
PE(LYR):-31.65

Loading ...

Adaptive Biotechnologies Shares up 11.4% Premarket After Co Announces Preliminary Q4, FY25 Results

THOMSON REUTERS
·
Jan 12

Adaptive Biotechnologies Corp - Preliminary Q4 Revenue $72 Mln

THOMSON REUTERS
·
Jan 12

Press Release: Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results

Dow Jones
·
Jan 12

The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following New Pfizer Immune-Data Deals And Spinout Financing – Learn Why

Simply Wall St.
·
Jan 11

Assessing Adaptive Biotechnologies (ADPT) Valuation After New Pfizer Deals And Digital Biotechnologies Financing

Simply Wall St.
·
Jan 09

CEO and Chairman Chad M. Robins Reports Sale of Adaptive Biotechnologies Common Shares

Reuters
·
Jan 08

Chief People Officer Francis Lo Reports Sale of Adaptive Biotechnologies Common Shares

Reuters
·
Jan 07

Adaptive Biotechnologies to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 31, 2025

Adaptive Biotechnologies Corp - to Retain Nearly 50% Ownership in Digital Biotechnologies - SEC Filing

THOMSON REUTERS
·
Dec 30, 2025

Adaptive Biotechnologies Affiliate Digital Biotechnologies Secures Up to $15 Million in Series A Financing

Reuters
·
Dec 30, 2025

Adaptive Biotechnologies (ADPT): Valuation Check After New Pfizer T-Cell Discovery and AI Drug Collaboration Deals

Simply Wall St.
·
Dec 23, 2025

Cathie Wood Dumps $11 Milllion Worth of Tesla Stock While Doubling Down on These Notable Crypto Plays

Benzinga
·
Dec 19, 2025

Pfizer Faces Another Quiet Year As Patent Losses Cloud 2026 Outlook: Analyst

Benzinga_recent_news
·
Dec 16, 2025

Adaptive Biotechnologies Signs Two Immune Receptor Licensing Agreements with Pfizer

Reuters
·
Dec 15, 2025

Adaptive Biotechnologies Corp - Pfizer to Use Adaptive's Platform for Rheumatoid Arthritis

THOMSON REUTERS
·
Dec 15, 2025

Adaptive Biotechnologies Corp - May Receive up to $890 Mln in Milestones

THOMSON REUTERS
·
Dec 15, 2025

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements With Pfizer

THOMSON REUTERS
·
Dec 15, 2025

Adaptive Biotechnologies Corp: Specific Financial Terms of Agreement Will Not Be Disclosed

THOMSON REUTERS
·
Dec 15, 2025

Director Robert Hershberg Reports Disposal of Adaptive Biotechnologies Common Shares

Reuters
·
Dec 13, 2025

Adaptive Biotechnologies Executives Join Jefferies Fireside Chat on Minimal Residual Disease

Reuters
·
Dec 10, 2025